Harald H. Sitte
Cited by
Cited by
Powerful cocaine-like actions of 3, 4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products
MH Baumann, JS Partilla, KR Lehner, EB Thorndike, AF Hoffman, M Holy, ...
Neuropsychopharmacology 38 (4), 552-562, 2013
Amphetamines, new psychoactive drugs and the monoamine transporter cycle
HH Sitte, M Freissmuth
Trends in pharmacological sciences 36 (1), 41-50, 2015
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport
JU Fog, H Khoshbouei, M Holy, WA Owens, CB Vaegter, N Sen, ...
Neuron 51 (4), 417-429, 2006
Carrier‐mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter
HH Sitte, S Huck, H Reither, S Boehm, EA Singer, C Pifl
Journal of neurochemistry 71 (3), 1289-1297, 1998
Oligomerization of the human serotonin transporter and of the rat GABA transporter 1 visualized by fluorescence resonance energy transfer microscopy in living cells
JA Schmid, P Scholze, O Kudlacek, M Freissmuth, EA Singer, HH Sitte
Journal of Biological Chemistry 276 (6), 3805-3810, 2001
Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation
AH Rajput, HH Sitte, A Rajput, ME Fenton, C Pifl, O Hornykiewicz
Neurology 70 (16_part_2), 1403-1410, 2008
Actovegin®: a biological drug for more than 5 decades.
F Buchmayer, J Pleiner, MW Elmlinger, G Lauer, G Nell, HH Sitte
Wiener Medizinische Wochenschrift (1946) 161 (3-4), 80-88, 2011
Shock wave treatment enhances cell proliferation and improves wound healing by ATP release-coupled extracellular signal-regulated kinase (ERK) activation
AM Weihs, C Fuchs, AH Teuschl, J Hartinger, P Slezak, R Mittermayr, ...
Journal of Biological Chemistry 289 (39), 27090-27104, 2014
Anomalous dopamine release associated with a human dopamine transporter coding variant
MS Mazei-Robison, E Bowton, M Holy, M Schmudermaier, M Freissmuth, ...
Journal of Neuroscience 28 (28), 7040-7046, 2008
Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3
LA Egaña, RA Cuevas, TB Baust, LA Parra, RK Leak, S Hochendoner, ...
Journal of Neuroscience 29 (14), 4592-4604, 2009
The N terminus of monoamine transporters is a lever required for the action of amphetamines
S Sucic, S Dallinger, B Zdrazil, R Weissensteiner, TN Jørgensen, M Holy, ...
Journal of Biological Chemistry 285 (14), 10924-10938, 2010
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD
FH Hansen, T Skjørringe, S Yasmeen, NV Arends, MA Sahai, K Erreger, ...
The Journal of clinical investigation 124 (7), 3107-3120, 2014
Sodium-dependent neurotransmitter transporters: oligomerization as a determinant of transporter function and trafficking
HH Sitte, H Farhan, JA Javitch
Molecular interventions 4 (1), 38, 2004
Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors
CJ Loland, RI Desai, MF Zou, J Cao, P Grundt, K Gerstbrein, HH Sitte, ...
Molecular pharmacology 73 (3), 813-823, 2008
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine
T Steinkellner, M Freissmuth, HH Sitte, T Montgomery
Walter de Gruyter 392 (1-2), 103-115, 2011
Mutations within an intramembrane leucine heptad repeat disrupt oligomer formation of the rat GABA transporter 1
P Scholze, M Freissmuth, HH Sitte
Journal of Biological Chemistry 277 (46), 43682-43690, 2002
Enhanced serotonin transporter function during depression in seasonal affective disorder
M Willeit, HH Sitte, N Thierry, K Michalek, N Praschak-Rieder, P Zill, ...
Neuropsychopharmacology 33 (7), 1503-1513, 2008
Reduced default mode network suppression during a working memory task in remitted major depression
L Bartova, BM Meyer, K Diers, U Rabl, C Scharinger, A Popovic, G Pail, ...
Journal of psychiatric research 64, 9-18, 2015
Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action
S Seidel, EA Singer, H Just, H Farhan, P Scholze, O Kudlacek, M Holy, ...
Molecular pharmacology 67 (1), 140-151, 2005
PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein
PJ Hamilton, AN Belovich, G Khelashvili, C Saunders, K Erreger, ...
Nature chemical biology 10 (7), 582-589, 2014
The system can't perform the operation now. Try again later.
Articles 1–20